Advarra
Latest Posts by Advarra
Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent
Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent For sponsors, informed...
Read More...
A More Connected Approach to Clinical Trials: Reducing Friction from Study Design Through Conduct
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when...
Read More...
Sponsor’s Guide to IRB Approval (Part II): How to Draft a Clinical Trial Protocol That Stands Up to IRB ScrutinyÂ
A strong clinical trial protocol does more than describe how a study will run. It...
Read More...
Emerging Use of Bacteriophages, Natural Predators of Bacteria, to Combat Antibiotic Resistance in the Clinic and Beyond: A Review of the Field and Biosafety Assessment
Read More...
New Framework Proposes Risk-Based Governance for AI in Clinical Development
First deliverable from the Council for Responsible Use of AI in Clinical Trials, a cross-industry...
Read More...
Sponsor’s Guide to IRB Approval: What Every Sponsor Needs to Know Before Submitting a Study
Introducing the “‘Sponsor’s Guide to IRB Approval’“ Institutional review board (IRB) approval protects the rights, safety, and...
Read More...
Q&A with Advarra’s Director of Training in IRB Services Lori Young
Lori Young has spent her career at the intersection of research, ethics, and education—and her...
Read More...
Advarra to Showcase Technology Innovations for Research Sites at Onsemble 2026
Columbia, MD – April 2, 2026 – Advarra, the industry leader in integrated solutions for...
Read More...
Q&A with Advarra’s Senior Coordinator of Client Services Jani VioxÂ
For Jani Viox, clinical research is more than a profession—it’s personal. As a senior coordinator of...
Read More...
How Smarter Clinical Trial Study Design Decisions Set Studies Up for Faster Startup and Fewer AmendmentsÂ
Clinical trial study design forms the foundation of trial success. The decisions teams make at...
Read More...